MTOR and canker sore: •Key Findings: Direct stick embolization of low-flow vascular malformations using a mammalian target of rapamycin (mTOR) inhibitor in 25 patients resulted in a clinical and technical success rate of 100%, no perioperative or delayed complications, and a side effect profile limited to seven cases of transient, self-limited aphthous ulcers.